Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
View on Grants.gov ↗ Sign in to save
- Type
- Grant
- Notice type
- G
- Agency
- National Institutes of Health
- Sub-agency
- HHS-NIH11
- Solicitation #
- RFA-AI-28-024
- Posted
- Oct 13, 2026
- Response due
- Feb 11, 2027
- Archive date
- Apr 13, 2027
- CFDA / Assistance listing
- 93.855
- Total program funding
- $4,000,000
- Contact
- MalariaandOtherMosquitoBorneDiseases@mail.nih.gov
- Source
- Grants.gov
Description
The purpose of this notice of funding opportunity (NOFO) is to support research and/or preclinical development of highly efficacious vaccines against malaria - one of the deadliest mosquito-borne diseases - by capitalizing on recent technological innovations, particularly in structure-based immunogen design, improved formulations, and combination vaccines. The goal is to achieve long-lasting, highly effective protection that can save lives, strengthen public health security in the United States, and serve as a model for, or are potentially effective against, other mosquito-borne diseases.